Epsilon M&A Deal Report - Eusa Pharma (UK)
Transaction Multiples for the Valuation of Private Companies
Recordati / Eusa Pharma (UK)
No EMAT :
109851
Announced Date :
03/12/2021
Type :
Exit ,Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Recordati
Target :
Eusa Pharma (UK)
Country :
England
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
Business Description :
Founded in March 2015, EUSA Pharma is a pharmaceutical company with a portfolio of 4 rare and niche oncology products. > Products include: Qarziba®, an anti-GD2 monoclonal antibody indicated for...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|||||
| Current |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 32
| Date | Acquirer | Target | Country | Multiples | See details |
| 30/04/2021 | Private Group led by EW Healthcare Partners | Laboratoires Majorelle | Paris | * | 109837 |
| 18/06/2021 | Ethypharm | Altan Pharma | Ireland | *** | 109827 |
Source: Epsilon Research / EMAT
